DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
1998 ◽
Vol 157
(4)
◽
pp. 1319-1323
◽
Keyword(s):
2012 ◽
Vol 109
(2)
◽
pp. 219-227
◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 21
(4)
◽
pp. 334-340
◽
Keyword(s):
2014 ◽
Vol 17
(3)
◽
pp. 209-214
◽
Keyword(s):